3,4-Dihydro-1-isoquinolinone - CAS 1196-38-9
Catalog: |
BB004562 |
Product Name: |
3,4-Dihydro-1-isoquinolinone |
CAS: |
1196-38-9 |
Synonyms: |
3,4-dihydro-2H-isoquinolin-1-one; 3,4-dihydro-2H-isoquinolin-1-one |
IUPAC Name: | 3,4-dihydro-2H-isoquinolin-1-one |
Description: | 3,4-Dihydro-1-isoquinolinone (CAS# 1196-38-9) is a useful research chemical. |
Molecular Weight: | 147.17 |
Molecular Formula: | C9H9NO |
Canonical SMILES: | C1CNC(=O)C2=CC=CC=C21 |
InChI: | InChI=1S/C9H9NO/c11-9-8-4-2-1-3-7(8)5-6-10-9/h1-4H,5-6H2,(H,10,11) |
InChI Key: | YWPMKTWUFVOFPL-UHFFFAOYSA-N |
Boiling Point: | 388.1 °C at 760 mmHg |
Density: | 1.142 g/cm3 |
Storage: | Sealed in dry, 2-8 °C |
MDL: | MFCD00853963 |
LogP: | 1.30130 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3891138-A1 | Fibroblast activation protein ligands for targeted delivery applications | 20200212 |
WO-2021160825-A1 | Fibroblast activation protein ligands for targeted delivery applications | 20200212 |
WO-2021155367-A2 | Negative allosteric modulation of glun3-containing n-methyl-d-aspartate receptors | 20200130 |
US-2021228562-A1 | Irak degraders and uses thereof | 20191217 |
WO-2021126728-A1 | Prmt5 inhibitors | 20191217 |
PMID | Publication Date | Title | Journal |
21784633 | 20110915 | Identification of novel allosteric modulators for the G-protein coupled US28 receptor of human cytomegalovirus | Bioorganic & medicinal chemistry letters |
20882963 | 20101108 | Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds | Journal of combinatorial chemistry |
21583149 | 20090514 | Methyl trans-(±)-1-oxo-2-phenethyl-3-(thio-phen-2-yl)-1,2,3,4-tetra-hydro-isoquinoline-4-carboxyl-ate | Acta crystallographica. Section E, Structure reports online |
21201159 | 20080917 | trans-rac-[1-Oxo-2-phenethyl-3-(2-thien-yl)-1,2,3,4-tetra-hydro-isoquinolin-4-yl]methyl 4-methyl-benzene-sulfonate | Acta crystallographica. Section E, Structure reports online |
17822096 | 20070801 | Quinoline and derivatives at a tar oil contaminated site: hydroxylated products as indicator for natural attenuation? | Environmental science & technology |
Complexity: | 167 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 147.068413911 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 147.068413911 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 29.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS